Personalized Vitamin D Supplementation Linked to Lower Risk of Repeat Heart Attacks
A new study published today, November 12, 2025, indicates that tailoring vitamin D supplementation to individual blood levels significantly reduces the risk of recurrent heart attacks in patients with existing heart disease.
Researchers at Intermountain Medical Center in Utah followed 630 adults diagnosed with acute heart disease over six years, finding that those receiving personalized vitamin D supplementation – guided by regular blood tests to maintain levels above 40 nanograms per milliliter (ng/mL) – experienced a 52 percent reduction in repeat heart attacks compared to a group receiving standard care. Nearly half of the participants had previously experienced a heart attack, and over 85 percent were initially vitamin D deficient. This finding is particularly significant given that heart disease remains the leading cause of death globally.
The study challenges the conventional “one-size-fits-all” approach to vitamin D dosing, emphasizing the importance of monitoring individual levels and adjusting intake accordingly. Researchers recommend blood tests every three months to avoid both under-supplementation and excessive intake, which can lead to hypercalcaemia. Optimizing vitamin D levels supports cardiovascular health by reducing inflammation, regulating blood pressure, and bolstering heart muscle function, as detailed by the American Heart Association.
Experts caution that personalized vitamin D supplementation should complement, not replace, standard heart care, including lifestyle modifications and prescribed medications. Further research is needed to validate these findings in larger, peer-reviewed studies, but the initial results suggest a potentially transformative approach to preventive cardiology. Doctors are encouraging patients to discuss their vitamin D levels with their healthcare providers and explore personalized supplementation options, as detailed in this Mayo Clinic resource.
Researchers will continue to analyze the data and advocate for wider adoption of vitamin D monitoring in cardiac care.
